Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes

Toxicon

Volumn 41, Issue 7, 2003, Pages 851-860

  Arce, Viviana ^a   Rojas, Ermila ^a   Ownby, Charlotte L ^b   Rojas, Gustavo ^a   Gutiérrez, José María ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Anticoral antivenom; Crotalinae; Elapidae; Neutralization; Polyvalent antivenom; Snake venom

Indexed keywords

PHOSPHOLIPASE A; SPIDER VENOM ANTISERUM; VENOM;

ARTICLE; BIOASSAY; CONTROLLED STUDY; COSTA RICA; IN VITRO STUDY; INCUBATION TIME; LD 50; LETHALITY; MOUSE; NEUROTOXICITY; NONHUMAN; NORTH AMERICA; PLASMA; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RACEMIC MIXTURE; SNAKE; TOXICITY;

AGKISTRODON; AGKISTRODON CONTORTRIX CONTORTRIX; AGKISTRODON PISCIVORUS PISCIVORUS; CROTALINAE; CROTALUS ADAMANTEUS; CROTALUS ATROX; CROTALUS HORRIDUS ATRICAUDATUS; CROTALUS SCUTULATUS; CROTALUS VIRIDIS VIRIDIS; ELAPIDAE; FULVIUS; MICRURUS FULVIUS; SERPENTES;

EID: 0038696349     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(03)00043-6     Document Type: Article

References (60)

1. 2 from the venom of the coral snake Micrurus nigrocinctus nigrocinctus. FEBS Letters. 380:1996;29-32.
2. Alape-Girón A., Persson B., Cederlund E., Flores-Díaz M., Gutiérrez J.M., Thelestam M., Bergman T., Jörnvall H. Elapid venom toxins: multiple recruitments of ancient scaffolds. Eur. J. Biochem. 259:1999;225-234.
3. Anderson S.G., Gutiérrez J.M., Ownby C.L. Comparison of the immunogenicity and antigenic composition of ten Central American snake venoms. Toxicon. 31:1993;1051-1059.
4. Angulo Y., Estrada R., Gutiérrez J.M. Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (Crotalinae) antivenom. Toxicon. 35:1997;81-90.
5. Bogarín G., Morais J.F., Yamaguchi I.K., Stephano M.A., Marcelino J.R., Nishikawa A.K., Guidolin R., Rojas G., Higashi H.G., Gutiérrez J.M. Neutralization of crotaline snake venoms from Central and South America by antivenoms produced in Brazil and Costa Rica. Toxicon. 38:2000;1429-1441.
6. Bolaños R., Cerdas L. Producción y control de sueros antiofídicos en Costa Rica. Bol. Of. Sanit. Panam. 88:1980;189-196.
7. Bolaños R., Cerdas L., Abalos J.W. Venenos de las serpientes coral (Micrurus spp.): informe sobre un antiveneno polivalente para las Americas. Bol. Of. Sanit. Panam. 84:1978;128-133.
8. Boyer L.V., Seifert S.A., Clark R.F., McNally J.T., Williams S.R., Nordt S.P., Walter F.G., Dart R.C. Recurrent and persistent coagulopathy following pit viper envenomation. Arch. Int. Med. 159:1999;706-710.
9. Boyer L.V., Seifert S.A., Cain J.S. Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 2. Guidelines for clinical management with crotaline Fab antivenom. Ann. Emerg. Med. 37:2001;196-201.
10. Bush S.P., Green S.M., Moynihan J.A., Hayes W.K., Cardwell M.D. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri). Ann. Emerg. Med. 40:2002;619-624.
11. Carroll R.R., Hall E.L., Kitchens C.S. Canebrake rattlesnake envenomation. Ann. Emerg. Med. 30:1997;45-48.
12. Cate R.L., Bieber A.L. Purification and characterization of mojave (Crotalus scutulatus scutulatus) toxin and its subunits. Arch. Biochem. Biophys. 189:1978;397-408.
13. Clark R.F., Williams S.R., Nordt S.P., Boyer-Hassen L.V. Successful treatment of crotalid-induced neurotoxicity with a new polyspecific crotalid Fab antivenom. Ann. Emerg. Med. 30:1997;54-57.
14. Consroe P., Egen N.B., Russell F.E., Gerrish K., Smith D.C., Sidki A., Landon J.T. Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice. Am. J. Trop. Med. Hyg. 53:1995;507-510.
15. Chippaux J.P. Snake-bites: appraisal of the global situation. Bull. World Health Organ. 76:1998;515-524.
16. Dart R.C., McNally J. Efficacy, safety, and use of snake antivenoms in the United States. Ann. Emerg. Med. 37:2001;181-188.
17. Dart R.C., McNally J.T., Spaite D.W., Gustafson R. The sequelae of pitviper poisoning in the United States. Campbell J.A., Brodie E.D. Biology of the Pitvipers. 1992;395-404 Selva Publishing, Texas.
18. Dart R.C., Seifert S.A., Carroll L., Clark R.F., Hall E., Boyer-Hassen L.V., Curry S.C., Kitchens C.S., García R.A. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann. Emerg. Med. 30:1997;33-39.
19. Dart R.C., Seifert S.A., Boyer L.V., Clark R.F., Hall E., McKinney P., McNally J., Kitchens C.S., Curry S.C., Bogdan G.M., Ward S.B., Porter R.S. A randomized multicenter trial of Crotalinae polyvalent immune Fab (ovine) antivenom for the treatment of Crotalidae snakebite in the United States. Arch. Int. Med. 161:2001;2030-2036.
20. De Roodt A.R., Dolab J.A., Fernández T., Segre L., Hajos S.E. Cross-reactivity and heterologous neutralization of crotaline antivenoms used in Argentina. Toxicon. 36:1998;1025-1038.
21. Dias da Silva W., Guidolin R., Raw I., Higashi H.G., Caricati C.P., Morais J.F., Lima M.L.S.R., Yamaguchi I.K., Nishikawa A.K., Stephano M.A., Marcelino J.R., Pinto J.R., Santos M.J. Cross-reactivity of horse monovalent antivenoms to venoms of ten Bothrops species. Mem. Inst. Butantan. 51:1989;153-168.
22. Gené J.A., Robles A. Determinación de la dosis letal 50% por el método de Spearman-Karber. Rev. Méd. Hosp. Nal. Niños (Costa Rica). 22:1987;25-40.
23. Gené J.A., Roy A., Rojas G., Gutiérrez J.M., Cerdas L. Comparative study on the coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom. Toxicon. 27:1989;841-848.
24. Glenn J.L., Straight R.C., Wolfe M.C., Hardy D.L. Geographical variation in Crotalus scutulatus (Mojave rattlesnake) venom properties. Toxicon. 21:1983;119-130.
25. Gold B.S., Dart R.C., Barish R.A. Bites by venomous snakes. N. Engl. J. Med. 347:2002;347-356.
26. Gómez H.F., Dart R.C. Clinical toxicology of snakebite in North America. Meier J., White J. Handbook of Clinical Toxicology of Animal Venoms and Poisons. 1995;619-644 CRC Press, Florida.
27. 2 myotoxins from Bothrops snake venoms. Toxicon. 33:1995;1405-1424.
28. Gutiérrez J.M., Rucavado A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie. 82:2000;841-850.
29. Gutiérrez J.M., Gené J.A., Rojas G., Cerdas L. Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom. Toxicon. 23:1985;887-893.
30. Gutiérrez J.M., Rojas G., Lomonte B., Gené J.A., Chaves F., Alvarado J., Rojas E. Standardization of assays for testing the neutralizing ability of antivenoms. Toxicon. 28:1990;1127-1129.
31. Gutiérrez J.M., Rojas G., Bogarín G., Lomonte B. Evaluation of the neutralizing ability of antivenoms for the treatment of snake bite envenoming in Central America. Bon C., Goyffon M. Envenomings and their Treatments. 1996;223-231 Fondation Marcel Mérieux, Lyon.
32. Heard K., O'Malley G.F., Dart R.C. Antivenom therapy in the Americas. Drugs. 58:1999;5-15.
33. Hendon R.A., Bieber A.L. Presynaptic toxins from rattlesnake venoms. Tu A.T. Rattlesnake Venoms. Their Actions and Treatment. 1982;211-246 Marcel Dekker, New York.
34. Holstege C.P., Miller M.B., Wermuth M., Furbee B., Curry S.C. Crotalid snake envenomation. Crit. Care Clin. 13:1997;889-921.
35. Jurkovich G.J., Luterman A., McCullar K., Ramenofsky M.L., Curreri P.W. Complications of Crotalidae antivenin therapy. J. Trauma. 28:1988;1032-1037.
36. Kitchens C.S., van Mierop L.H.S. Envenomation by the eastern coral snake (Micrurus fulvius fulvius). JAMA. 258:1987;1615-1618.
37. Markland F.S. Snake venoms and the hemostatic system. Toxicon. 36:1998;1749-1800.
38. Markland F.S., Damus P.S. Purification and properties of a thrombin-like enzyme from the venom of Crotalus adamanteus (eastern diamondback rattlesnake). J. Biol. Chem. 246:1971;6460-6473.
39. Mebs D., Pohlmann S., von Tenspolde W. Snake venom hemorrhagins: neutralization by commercial antivenoms. Toxicon. 26:1988;453-458.
40. Meier J. Commercially available antivenoms (hyperimmune sera, antivenins, antisera) for antivenom therapy. Meier J., White J. Handbook of Clinical Toxicology of Animal Venoms and Poisons. 1995;689-721 CRC Press, Florida.
41. Moura da Silva A.M., D'Imperio Lima M.R., Nishikawa A.K., Brodskyn C.I., dos Santos M.C., Furtado M.F.D., Dias da Silva W., Mota I. Antigenic cross reactivity of venoms obtained from snakes of the genus Bothrops. Toxicon. 28:1990;181-188.
42. Otero R., Núñez V., Osorio R.G., Gutiérrez J.M., Giraldo C.A., Posada L.E. Ability of six Latin American antivenoms to neutralize the venom of Mapaná Equis (Bothrops atrox) from Antioquia and Chocó (Colombia). Toxicon. 33:1995;809-815.
43. Ownby C.L. Pathology of rattlesnake envenomation. Tu A.T. Their Actions and Treatment. 1982;163-209 Marcel Dekker, New York.
44. Ownby C.L. Locally acting agents: myotoxins, hemorrhagic toxins and dermonecrotic factors. Shier, Mebs. Handbook of Toxinology. 1990;601-654 Marcel Dekker, New York.
45. Ownby C.L., Bjarnason J.B., Tu A.T. Hemorrhagic toxins from rattlesnake (Crotalus atrox) venom. Pathogenesis of hemorrhage induced by three purified toxins. Am. J. Pathol. 93:1978;201-218.
46. Reid H.A., Theakston R.D.G. Changes in coagulation effects by venoms of Crotalus atrox as snakes age. Am. J. Trop. Med. Hyg. 27:1978;1053-1057.
47. Rojas G., Jiménez J.M., Gutiérrez J.M. Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production. Toxicon. 32:1994;351-363.
48. 2 activities from Micrurus venoms. Determination of the amino acid sequence and receptor-binding ability of the major α-neurotoxin from Micrurus nigrocinctus nigrocinctus. Eur. J. Biochem. 238:1996;231-239.
49. Ruha A.M., Curry S.C., Beuhler M., Katz K., Brooks D.E., Graeme K.A., Wallace K., Gerkin R., LoVecchio F., Wax P., Selden B. Initial postmarketing experience with Crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann. Emerg. Med. 39:2002;609-615.
50. Russell F.E. Snake venom immunology: historical and practical considerations. J. Toxicol. Toxin Rev. 7:1988;1-82.
51. Russell F.E. Snake venom poisoning in the United States of America. Bon C., Goyffon M. Envenomings and their Treatments. 1996;235-245 Fondation Marcel Mérieux, Lyon.
52. Saravia P., Rojas E., Arce V., Guevara C., López J.C., Chaves E., Velásquez R., Rojas G., Gutiérrez J.M. Geographic and ontogenic variability in the venom of the neotropical rattlesnake Crotalus durissus: pathophysiological and therapeutic implications. Rev. Biol. Trop. 50:2002;337-346.
53. Scharman E.J., Noffsinger V.D. Copperhead snakebites: clinical severity of local effects. Ann. Emerg. Med. 38:2001;55-61.
54. Seifert S.A., Boyer L.V. Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies. Ann. Emerg. Med. 37:2001;189-195.
55. Solórzano A., Romero M., Gutiérrez J.M., Sasa M. Venom composition and diet of the cantil Agkistrodon bilineatus howardgloydi (Serpentes: Viperidae). Southwestern Nat. 44:1999;478-483.
56. Shu Y.Y., Moran J.B., Geren C.R. A thrombin-like enzyme from timber rattlesnake venom. Biochim. Biophys. Acta. 748:1983;236-244.
57. Theakston R.D.G. Characterization of venoms and standardization of antivenoms. Harris J.B. Natural Toxins. Animal, Plant and Microbial. 1986;287-303 Clarendon Press, Oxford.
58. Theakston R.D.G., Reid H.A. Development of simple standard assay procedures for the characterization of snake venoms. Bull. World Health Org. 61:1983;949-956.
59. Theakston R.D.G., Warrell D.A. Antivenoms: a list of hyperimmune sera currently available for the treatment of envenoming by bites and stings. Toxicon. 29:1991;1419-1470.
60. Progress in the Characterization of Venoms and Standardization of Antivenoms. 1981;WHO Offset Publication 58, Geneva.